For the year ending 2025-12-31, XRAY made $3,680M in revenue. -$598M in net income. Net profit margin of -16.25%.
| Income Statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Net sales | 3,680 | 3,793 | 3,965 | 3,922 |
| Cost of products sold | 1,840 | 1,835 | 1,879 | 1,795 |
| Gross profit | 1,840 | 1,958 | 2,086 | 2,127 |
| Selling, general, and administrative expenses | 1,438 | 1,605 | 1,613 | 1,589 |
| Research and development expenses | 150 | 165 | 184 | 174 |
| Goodwill impairment | - | - | - | 1,187 |
| Goodwill and intangible asset impairments | 650 | 1,014 | 307 | - |
| Intangible asset impairment and other costs | - | - | - | 114 |
| Restructuring costs | 24 | 53 | 67 | - |
| Operating loss | -422 | -879 | -85 | -937 |
| Interest expense, net | 88 | 69 | 81 | -60 |
| Other (income) expense, net | 24 | 12 | -9 | -58 |
| Loss before income taxes | -486 | -936 | -175 | -1,055 |
| Provision (benefit) for income taxes | 112 | -26 | -43 | -105 |
| Net loss | -598 | -910 | -132 | -950 |
| Less net loss attributable to noncontrolling interests | 0 | 0 | 0 | 0 |
| Net loss attributable to dentsply sirona | -598 | -910 | -132 | -950 |
| Basic EPS | -3 | -4.48 | -0.62 | -4.41 |
| Diluted EPS | -3 | -4.48 | -0.62 | -4.41 |
| Basic Average Shares | 199,400,000 | 203,200,000 | 212,000,000 | 215,500,000 |
| Diluted Average Shares | 199,400,000 | 203,200,000 | 212,000,000 | 215,500,000 |
DENTSPLY SIRONA Inc. (XRAY)
DENTSPLY SIRONA Inc. (XRAY)